Skip to main content
Clinical Trials/NCT01627535
NCT01627535
Completed
Not Applicable

Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors

City of Hope Medical Center1 site in 1 country4 target enrollmentMay 2013
ConditionsBrain Tumor

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Tumor
Sponsor
City of Hope Medical Center
Enrollment
4
Locations
1
Primary Endpoint
Intraoperative determination of the location of critical brain functions.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This clinical trial studies optical imaging in assessing activity during surgery in patients with brain tumors. New procedures, such as optical spectroscopy, may help doctors maximally remove brain tumors and minimize damage to normal brain.

Detailed Description

PRIMARY OBJECTIVES: I. To develop the instrumentation to achieve real time processing and display of intraoperative 2-dimensional optical imaging and spectroscopy (i2DOS) maps in the operating arena. II. To examine the timing and spatial involvement of human cortex intraoperatively to different stimuli using i2DOS. OUTLINE: Patients undergo i2DOS.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
January 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
City of Hope Medical Center
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Neurosurgical patient population in the City of Hope brain and spinal tumor neurosurgical programs that have been diagnosed with a brain tumor.
  • Only lucid patients qualified to consent to neurosurgical procedure will be approached for participation in this study.
  • We do intend to enroll subjects with potentially terminal brain tumors. Due to the potential benefit of intraoperative mapping, we are not planning to exclude these subjects.
  • Patients with any type of brain tumor will be eligible for participation.
  • All subjects must have the ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria

  • There are no exclusion criteria except for individuals without a brain tumor and the location of the craniotomy. If the exposed area of brain is not compatible with peripheral stimuli or volitional activity the subject cannot be enrolled.
  • Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.

Outcomes

Primary Outcomes

Intraoperative determination of the location of critical brain functions.

Time Frame: Day 1 post surgery

We will examine the timing and spatial involvement of human cortex intraoperatively to different stimuli using i2DOS. Stimulus parameters will be varied to investigate stimulus-response relationships. We will study areas of sensori-motor and language cortex using customary stimuli for evoked potentials (i.e. transcutaneous electrical nerve stimulation), tactile stimuli for exposed cortical dermatome representations, and language tasks for cortical language representations. Results will be correlated with intraoperative electrophysiological measures.

Determination of the effectiveness of intraoperative optical imaging technology and optical spectroscopy.

Time Frame: Day 1 post surgery

Optical reflectance images will be analyzed by pixel by-pixel subtraction of a control trial and a stimulation trial. This subtracted image will then be divided by the control image to normalize for differences between subjects and trials. These ratios thus represent proportional changes from baseline.

Study Sites (1)

Loading locations...

Similar Trials